ID: ALA1765806

Max Phase: Preclinical

Molecular Formula: C26H22N2O2S

Molecular Weight: 426.54

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCN(CC)c1ccc(-c2ccc3cc(-c4nc5ccccc5s4)c(=O)oc3c2)cc1

Standard InChI:  InChI=1S/C26H22N2O2S/c1-3-28(4-2)20-13-11-17(12-14-20)18-9-10-19-15-21(26(29)30-23(19)16-18)25-27-22-7-5-6-8-24(22)31-25/h5-16H,3-4H2,1-2H3

Standard InChI Key:  QRJIKSVOOMDBDK-UHFFFAOYSA-N

Associated Targets(non-human)

Myelin basic protein 42 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 426.54Molecular Weight (Monoisotopic): 426.1402AlogP: 6.58#Rotatable Bonds: 5
Polar Surface Area: 46.34Molecular Species: NEUTRALHBA: 5HBD: 0
#RO5 Violations: 1HBA (Lipinski): 4HBD (Lipinski): 0#RO5 Violations (Lipinski): 1
CX Acidic pKa: CX Basic pKa: 5.62CX LogP: 6.44CX LogD: 6.43
Aromatic Rings: 5Heavy Atoms: 31QED Weighted: 0.30Np Likeness Score: -1.21

References

1. Wang C, Wu C, Zhu J, Miller RH, Wang Y..  (2011)  Design, synthesis, and evaluation of coumarin-based molecular probes for imaging of myelination.,  54  (7): [PMID:21391687] [10.1021/jm101489w]

Source